ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cell and Advanced Therapies Supply Chain Management Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-8N13707
Home | Market Reports | Health| Nursing
Global Cell and Advanced Therapies Supply Chain Management Market Research Report 2023
BUY CHAPTERS

Global Cell and Advanced Therapies Supply Chain Management Market Research Report 2025

Code: QYRE-Auto-8N13707
Report
June 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Be The Match BioTherapies
Brooks Life Sciences
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
Mak-System
MasterControl
SAP
SAVSU Technologies
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink
TrakCel
Vineti

Cell and Advanced Therapies Supply Chain Management Market

The global market for Cell and Advanced Therapies Supply Chain Management was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cell and Advanced Therapies Supply Chain Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cell and Advanced Therapies Supply Chain Management is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cell and Advanced Therapies Supply Chain Management in Biobank is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cell and Advanced Therapies Supply Chain Management include Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cell and Advanced Therapies Supply Chain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Advanced Therapies Supply Chain Management.
The Cell and Advanced Therapies Supply Chain Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cell and Advanced Therapies Supply Chain Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Advanced Therapies Supply Chain Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cell and Advanced Therapies Supply Chain Management Market Report

Report Metric Details
Report Name Cell and Advanced Therapies Supply Chain Management Market
Segment by Type
  • Cloud
  • On-premises
Segment by Application
  • Biobank
  • Cell Therapy Lab
  • Hospital
  • Research Institute
  • Commercial Organization
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, SAVSU Technologies, sedApta Group, Stafa Cellular Therapy, Title21 Health Solutions, TraceLink, TrakCel, Vineti
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cell and Advanced Therapies Supply Chain Management company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cell and Advanced Therapies Supply Chain Management Market report?

Ans: The main players in the Cell and Advanced Therapies Supply Chain Management Market are Be The Match BioTherapies, Brooks Life Sciences, Clarkston Consulting, Cryoport, Haemonetics, Hypertrust Patient Data Care, Lykan Bioscience, MAK-SYSTEM, MasterControl, SAP, SAVSU Technologies, sedApta Group, Stafa Cellular Therapy, Title21 Health Solutions, TraceLink, TrakCel, Vineti

What are the Application segmentation covered in the Cell and Advanced Therapies Supply Chain Management Market report?

Ans: The Applications covered in the Cell and Advanced Therapies Supply Chain Management Market report are Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization

What are the Type segmentation covered in the Cell and Advanced Therapies Supply Chain Management Market report?

Ans: The Types covered in the Cell and Advanced Therapies Supply Chain Management Market report are Cloud, On-premises

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cloud
1.2.3 On-premises
1.3 Market by Application
1.3.1 Global Cell and Advanced Therapies Supply Chain Management Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biobank
1.3.3 Cell Therapy Lab
1.3.4 Hospital
1.3.5 Research Institute
1.3.6 Commercial Organization
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell and Advanced Therapies Supply Chain Management Market Perspective (2020-2031)
2.2 Global Cell and Advanced Therapies Supply Chain Management Growth Trends by Region
2.2.1 Global Cell and Advanced Therapies Supply Chain Management Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cell and Advanced Therapies Supply Chain Management Historic Market Size by Region (2020-2025)
2.2.3 Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Region (2026-2031)
2.3 Cell and Advanced Therapies Supply Chain Management Market Dynamics
2.3.1 Cell and Advanced Therapies Supply Chain Management Industry Trends
2.3.2 Cell and Advanced Therapies Supply Chain Management Market Drivers
2.3.3 Cell and Advanced Therapies Supply Chain Management Market Challenges
2.3.4 Cell and Advanced Therapies Supply Chain Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue
3.1.1 Global Top Cell and Advanced Therapies Supply Chain Management Players by Revenue (2020-2025)
3.1.2 Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Players (2020-2025)
3.2 Global Cell and Advanced Therapies Supply Chain Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cell and Advanced Therapies Supply Chain Management Revenue
3.4 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio
3.4.1 Global Cell and Advanced Therapies Supply Chain Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Advanced Therapies Supply Chain Management Revenue in 2024
3.5 Global Key Players of Cell and Advanced Therapies Supply Chain Management Head office and Area Served
3.6 Global Key Players of Cell and Advanced Therapies Supply Chain Management, Product and Application
3.7 Global Key Players of Cell and Advanced Therapies Supply Chain Management, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell and Advanced Therapies Supply Chain Management Breakdown Data by Type
4.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Type (2020-2025)
4.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2026-2031)
5 Cell and Advanced Therapies Supply Chain Management Breakdown Data by Application
5.1 Global Cell and Advanced Therapies Supply Chain Management Historic Market Size by Application (2020-2025)
5.2 Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cell and Advanced Therapies Supply Chain Management Market Size (2020-2031)
6.2 North America Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025)
6.4 North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Advanced Therapies Supply Chain Management Market Size (2020-2031)
7.2 Europe Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025)
7.4 Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size (2020-2031)
8.2 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2020-2025)
8.4 Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell and Advanced Therapies Supply Chain Management Market Size (2020-2031)
9.2 Latin America Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025)
9.4 Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size (2020-2031)
10.2 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025)
10.4 Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Be The Match BioTherapies
11.1.1 Be The Match BioTherapies Company Details
11.1.2 Be The Match BioTherapies Business Overview
11.1.3 Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Introduction
11.1.4 Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.1.5 Be The Match BioTherapies Recent Development
11.2 Brooks Life Sciences
11.2.1 Brooks Life Sciences Company Details
11.2.2 Brooks Life Sciences Business Overview
11.2.3 Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Introduction
11.2.4 Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.2.5 Brooks Life Sciences Recent Development
11.3 Clarkston Consulting
11.3.1 Clarkston Consulting Company Details
11.3.2 Clarkston Consulting Business Overview
11.3.3 Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Introduction
11.3.4 Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.3.5 Clarkston Consulting Recent Development
11.4 Cryoport
11.4.1 Cryoport Company Details
11.4.2 Cryoport Business Overview
11.4.3 Cryoport Cell and Advanced Therapies Supply Chain Management Introduction
11.4.4 Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.4.5 Cryoport Recent Development
11.5 Haemonetics
11.5.1 Haemonetics Company Details
11.5.2 Haemonetics Business Overview
11.5.3 Haemonetics Cell and Advanced Therapies Supply Chain Management Introduction
11.5.4 Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.5.5 Haemonetics Recent Development
11.6 Hypertrust Patient Data Care
11.6.1 Hypertrust Patient Data Care Company Details
11.6.2 Hypertrust Patient Data Care Business Overview
11.6.3 Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Introduction
11.6.4 Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.6.5 Hypertrust Patient Data Care Recent Development
11.7 Lykan Bioscience
11.7.1 Lykan Bioscience Company Details
11.7.2 Lykan Bioscience Business Overview
11.7.3 Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Introduction
11.7.4 Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.7.5 Lykan Bioscience Recent Development
11.8 MAK-SYSTEM
11.8.1 MAK-SYSTEM Company Details
11.8.2 MAK-SYSTEM Business Overview
11.8.3 MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Introduction
11.8.4 MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.8.5 MAK-SYSTEM Recent Development
11.9 MasterControl
11.9.1 MasterControl Company Details
11.9.2 MasterControl Business Overview
11.9.3 MasterControl Cell and Advanced Therapies Supply Chain Management Introduction
11.9.4 MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.9.5 MasterControl Recent Development
11.10 SAP
11.10.1 SAP Company Details
11.10.2 SAP Business Overview
11.10.3 SAP Cell and Advanced Therapies Supply Chain Management Introduction
11.10.4 SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.10.5 SAP Recent Development
11.11 SAVSU Technologies
11.11.1 SAVSU Technologies Company Details
11.11.2 SAVSU Technologies Business Overview
11.11.3 SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Introduction
11.11.4 SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.11.5 SAVSU Technologies Recent Development
11.12 sedApta Group
11.12.1 sedApta Group Company Details
11.12.2 sedApta Group Business Overview
11.12.3 sedApta Group Cell and Advanced Therapies Supply Chain Management Introduction
11.12.4 sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.12.5 sedApta Group Recent Development
11.13 Stafa Cellular Therapy
11.13.1 Stafa Cellular Therapy Company Details
11.13.2 Stafa Cellular Therapy Business Overview
11.13.3 Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Introduction
11.13.4 Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.13.5 Stafa Cellular Therapy Recent Development
11.14 Title21 Health Solutions
11.14.1 Title21 Health Solutions Company Details
11.14.2 Title21 Health Solutions Business Overview
11.14.3 Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Introduction
11.14.4 Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.14.5 Title21 Health Solutions Recent Development
11.15 TraceLink
11.15.1 TraceLink Company Details
11.15.2 TraceLink Business Overview
11.15.3 TraceLink Cell and Advanced Therapies Supply Chain Management Introduction
11.15.4 TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.15.5 TraceLink Recent Development
11.16 TrakCel
11.16.1 TrakCel Company Details
11.16.2 TrakCel Business Overview
11.16.3 TrakCel Cell and Advanced Therapies Supply Chain Management Introduction
11.16.4 TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.16.5 TrakCel Recent Development
11.17 Vineti
11.17.1 Vineti Company Details
11.17.2 Vineti Business Overview
11.17.3 Vineti Cell and Advanced Therapies Supply Chain Management Introduction
11.17.4 Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
11.17.5 Vineti Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Be The Match BioTherapies
Brooks Life Sciences
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
Mak-System
MasterControl
SAP
SAVSU Technologies
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink
TrakCel
Vineti
List of Tables
 Table 1. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Cloud
 Table 3. Key Players of On-premises
 Table 4. Global Cell and Advanced Therapies Supply Chain Management Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cell and Advanced Therapies Supply Chain Management Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cell and Advanced Therapies Supply Chain Management Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region (2020-2025)
 Table 8. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region (2026-2031)
 Table 10. Cell and Advanced Therapies Supply Chain Management Market Trends
 Table 11. Cell and Advanced Therapies Supply Chain Management Market Drivers
 Table 12. Cell and Advanced Therapies Supply Chain Management Market Challenges
 Table 13. Cell and Advanced Therapies Supply Chain Management Market Restraints
 Table 14. Global Cell and Advanced Therapies Supply Chain Management Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players (2020-2025)
 Table 16. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2024)
 Table 17. Ranking of Global Top Cell and Advanced Therapies Supply Chain Management Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cell and Advanced Therapies Supply Chain Management, Headquarters and Area Served
 Table 20. Global Key Players of Cell and Advanced Therapies Supply Chain Management, Product and Application
 Table 21. Global Key Players of Cell and Advanced Therapies Supply Chain Management, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cell and Advanced Therapies Supply Chain Management Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2020-2025)
 Table 25. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Type (2026-2031)
 Table 27. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2020-2025)
 Table 29. Global Cell and Advanced Therapies Supply Chain Management Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cell and Advanced Therapies Supply Chain Management Revenue Market Share by Application (2026-2031)
 Table 31. North America Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Be The Match BioTherapies Company Details
 Table 47. Be The Match BioTherapies Business Overview
 Table 48. Be The Match BioTherapies Cell and Advanced Therapies Supply Chain Management Product
 Table 49. Be The Match BioTherapies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 50. Be The Match BioTherapies Recent Development
 Table 51. Brooks Life Sciences Company Details
 Table 52. Brooks Life Sciences Business Overview
 Table 53. Brooks Life Sciences Cell and Advanced Therapies Supply Chain Management Product
 Table 54. Brooks Life Sciences Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 55. Brooks Life Sciences Recent Development
 Table 56. Clarkston Consulting Company Details
 Table 57. Clarkston Consulting Business Overview
 Table 58. Clarkston Consulting Cell and Advanced Therapies Supply Chain Management Product
 Table 59. Clarkston Consulting Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 60. Clarkston Consulting Recent Development
 Table 61. Cryoport Company Details
 Table 62. Cryoport Business Overview
 Table 63. Cryoport Cell and Advanced Therapies Supply Chain Management Product
 Table 64. Cryoport Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 65. Cryoport Recent Development
 Table 66. Haemonetics Company Details
 Table 67. Haemonetics Business Overview
 Table 68. Haemonetics Cell and Advanced Therapies Supply Chain Management Product
 Table 69. Haemonetics Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 70. Haemonetics Recent Development
 Table 71. Hypertrust Patient Data Care Company Details
 Table 72. Hypertrust Patient Data Care Business Overview
 Table 73. Hypertrust Patient Data Care Cell and Advanced Therapies Supply Chain Management Product
 Table 74. Hypertrust Patient Data Care Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 75. Hypertrust Patient Data Care Recent Development
 Table 76. Lykan Bioscience Company Details
 Table 77. Lykan Bioscience Business Overview
 Table 78. Lykan Bioscience Cell and Advanced Therapies Supply Chain Management Product
 Table 79. Lykan Bioscience Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 80. Lykan Bioscience Recent Development
 Table 81. MAK-SYSTEM Company Details
 Table 82. MAK-SYSTEM Business Overview
 Table 83. MAK-SYSTEM Cell and Advanced Therapies Supply Chain Management Product
 Table 84. MAK-SYSTEM Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 85. MAK-SYSTEM Recent Development
 Table 86. MasterControl Company Details
 Table 87. MasterControl Business Overview
 Table 88. MasterControl Cell and Advanced Therapies Supply Chain Management Product
 Table 89. MasterControl Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 90. MasterControl Recent Development
 Table 91. SAP Company Details
 Table 92. SAP Business Overview
 Table 93. SAP Cell and Advanced Therapies Supply Chain Management Product
 Table 94. SAP Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 95. SAP Recent Development
 Table 96. SAVSU Technologies Company Details
 Table 97. SAVSU Technologies Business Overview
 Table 98. SAVSU Technologies Cell and Advanced Therapies Supply Chain Management Product
 Table 99. SAVSU Technologies Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 100. SAVSU Technologies Recent Development
 Table 101. sedApta Group Company Details
 Table 102. sedApta Group Business Overview
 Table 103. sedApta Group Cell and Advanced Therapies Supply Chain Management Product
 Table 104. sedApta Group Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 105. sedApta Group Recent Development
 Table 106. Stafa Cellular Therapy Company Details
 Table 107. Stafa Cellular Therapy Business Overview
 Table 108. Stafa Cellular Therapy Cell and Advanced Therapies Supply Chain Management Product
 Table 109. Stafa Cellular Therapy Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 110. Stafa Cellular Therapy Recent Development
 Table 111. Title21 Health Solutions Company Details
 Table 112. Title21 Health Solutions Business Overview
 Table 113. Title21 Health Solutions Cell and Advanced Therapies Supply Chain Management Product
 Table 114. Title21 Health Solutions Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 115. Title21 Health Solutions Recent Development
 Table 116. TraceLink Company Details
 Table 117. TraceLink Business Overview
 Table 118. TraceLink Cell and Advanced Therapies Supply Chain Management Product
 Table 119. TraceLink Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 120. TraceLink Recent Development
 Table 121. TrakCel Company Details
 Table 122. TrakCel Business Overview
 Table 123. TrakCel Cell and Advanced Therapies Supply Chain Management Product
 Table 124. TrakCel Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 125. TrakCel Recent Development
 Table 126. Vineti Company Details
 Table 127. Vineti Business Overview
 Table 128. Vineti Cell and Advanced Therapies Supply Chain Management Product
 Table 129. Vineti Revenue in Cell and Advanced Therapies Supply Chain Management Business (2020-2025) & (US$ Million)
 Table 130. Vineti Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. Cell and Advanced Therapies Supply Chain Management Picture
 Figure 2. Global Cell and Advanced Therapies Supply Chain Management Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cell and Advanced Therapies Supply Chain Management Market Share by Type: 2024 VS 2031
 Figure 4. Cloud Features
 Figure 5. On-premises Features
 Figure 6. Global Cell and Advanced Therapies Supply Chain Management Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cell and Advanced Therapies Supply Chain Management Market Share by Application: 2024 VS 2031
 Figure 8. Biobank Case Studies
 Figure 9. Cell Therapy Lab Case Studies
 Figure 10. Hospital Case Studies
 Figure 11. Research Institute Case Studies
 Figure 12. Commercial Organization Case Studies
 Figure 13. Cell and Advanced Therapies Supply Chain Management Report Years Considered
 Figure 14. Global Cell and Advanced Therapies Supply Chain Management Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Cell and Advanced Therapies Supply Chain Management Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Cell and Advanced Therapies Supply Chain Management Market Share by Region: 2024 VS 2031
 Figure 17. Global Cell and Advanced Therapies Supply Chain Management Market Share by Players in 2024
 Figure 18. Global Top Cell and Advanced Therapies Supply Chain Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Advanced Therapies Supply Chain Management as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Cell and Advanced Therapies Supply Chain Management Revenue in 2024
 Figure 20. North America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2020-2031)
 Figure 22. United States Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Cell and Advanced Therapies Supply Chain Management Market Share by Country (2020-2031)
 Figure 26. Germany Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Cell and Advanced Therapies Supply Chain Management Market Share by Region (2020-2031)
 Figure 34. China Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Cell and Advanced Therapies Supply Chain Management Market Share by Country (2020-2031)
 Figure 42. Mexico Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Cell and Advanced Therapies Supply Chain Management Market Share by Country (2020-2031)
 Figure 46. Turkey Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Cell and Advanced Therapies Supply Chain Management Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Be The Match BioTherapies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 50. Brooks Life Sciences Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 51. Clarkston Consulting Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 52. Cryoport Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 53. Haemonetics Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 54. Hypertrust Patient Data Care Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 55. Lykan Bioscience Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 56. MAK-SYSTEM Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 57. MasterControl Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 58. SAP Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 59. SAVSU Technologies Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 60. sedApta Group Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 61. Stafa Cellular Therapy Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 62. Title21 Health Solutions Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 63. TraceLink Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 64. TrakCel Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 65. Vineti Revenue Growth Rate in Cell and Advanced Therapies Supply Chain Management Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Cell and Gene Therapy Supply Chain and Logistics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Clinical Supply Chain Management Market Research Report 2025
Global Clinical Trial Supply Chain Management Market Research Report 2024
Global Cell Therapy Manufacturing Market Research Report 2025
Global Medical Device Supply Chain Management Market Research Report 2024
Global Medical Supply Chain Management System Market Research Report 2024
Global Medical Supply Chain Management Solutions Market Research Report 2025
Global Cell Based Regenerative Therapy Market Research Report 2024
Global Medical Consumables Supply Chain Management Market Research Report 2024
Global Clinical Logistics Management Market Research Report 2024
Cell and Gene Therapy Cold Chain Logistics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cell and Gene Supply Chain Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cell Based Immunotherapy Market Research Report 2024
Global Automotive Supply Chain Management Solutions Market Research Report 2025
Global Advanced Cell Therapies Market Research Report 2024
Global Clinical Supply Chain Software Market Research Report 2024
Closed Cell Processing Systems for Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Supply Chain Management Service Market Research Report 2025
Global Cell Processing System Market Research Report 2025
Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Persistent Epithelial Defect Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-2O19977
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Intelligent Elderly Care Equipment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E8132
Wed Sep 17 00:00:00 UTC 2025

Add to Cart

Global Radiation Monitoring Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23I7304
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Global Ophthalmology Homeopathic Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8T5982
Tue Sep 16 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions